Bruno Delafont

1.2k total citations
19 papers, 894 citations indexed

About

Bruno Delafont is a scholar working on Emergency Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruno Delafont has authored 19 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Emergency Medicine, 3 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno Delafont's work include Cardiac Arrest and Resuscitation (4 papers), CAR-T cell therapy research (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Bruno Delafont is often cited by papers focused on Cardiac Arrest and Resuscitation (4 papers), CAR-T cell therapy research (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Bruno Delafont collaborates with scholars based in United Kingdom, United States and France. Bruno Delafont's co-authors include Hans J. Woerle, Jianping Weng, Uli C. Broedl, Gabriel Kim, Michael Roden, Raj Kumar Sharma, Job van der Palen, Mike Thomas, Henry Chrystyn and Neil Barnes and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Clinical Pharmacology & Therapeutics.

In The Last Decade

Bruno Delafont

17 papers receiving 872 citations

Peers

Countries citing papers authored by Bruno Delafont

Since Specialization

Citations

This map shows the geographic impact of Bruno Delafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Delafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Delafont more than expected).

Fields of papers citing papers by Bruno Delafont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Delafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Delafont. The network helps show where Bruno Delafont may publish in the future.

Co-authorship network of co-authors of Bruno Delafont

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Delafont. A scholar is included among the top collaborators of Bruno Delafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Delafont. Bruno Delafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Estimands in CNS trials – A review of strategies for addressing intercurrent events 2024 ·Contemporary Clinical Trials Communications ·(unknown), (unknown), Bruno Delafont, Lorenzo Guizzaro	0
2	Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma 2021 ·Nature Communications ·Antoni Ribas, Alain P. Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael S. Gordon, Leonel F. Hernandez‐Aya, Donald P. Lawrence, Jose Lutzky, Wilson H. Miller, Katie M. Campbell, Bruno Delafont, Shannon Marshall, Nancy K. Mueller, Caroline Robert	1
3	PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma 2020 ·Nature Communications ·Antoni Ribas, Alain P. Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael S. Gordon, Leonel F. Hernandez‐Aya, Donald P. Lawrence, Jose Lutzky, Wilson H. Miller, Katie M. Campbell, Bruno Delafont, Shannon Marshall, Nancy K. Mueller, Caroline Robert	60
4	Folate metabolism biomarkers from two randomised placebo-controlled clinical studies with paroxetine and venlafaxine 2020 ·The World Journal of Biological Psychiatry ·Lucia Carboni, Bruno Delafont, (unknown), Emiliangelo Ratti, Susan M. Learned, Robert Alexander, Enrico Domenici	1
5	A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Vincent Ribrag, Seung‐Tae Lee, David A. Rizzieri, Martin J.S. Dyer, Luis Fayad, Razelle Kurzrock, Leslie A. Andritsos, Réda Bouabdallah, (unknown), (unknown), Yu Jiang, (unknown), Bruno Delafont, Oday Hamid, (unknown), (unknown), Brian Hess	19
6	When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis? 2020 ·Brain Communications ·Jean‐Michel Graciès, Robert Jech, Peter Valkovič, P. Marqué, Michele Vecchio, Zoltán Dénes, Claire Vilain, Bruno Delafont, Philippe Picaut	9
7	Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies 2019 ·Translational Psychiatry ·Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, Michele Filosi, (unknown), Emiliangelo Ratti, Susan M. Learned, Robert Alexander, Enrico Domenici	65
8	Investigation of mixed model repeated measures analyses and non‐linear random coefficient models in the context of long‐term efficacy data 2018 ·Pharmaceutical Statistics ·Bruno Delafont, Kevin Carroll, Claire Vilain, Emmanuel Pham	2
9	Device errors in asthma and COPD: systematic literature review and meta-analysis 2017 ·npj Primary Care Respiratory Medicine ·Henry Chrystyn, Job van der Palen, Raj Kumar Sharma, Neil Barnes, Bruno Delafont, Anadi Mahajan, Mike Thomas	160
10	A usability study of a critical man–machine interface: Can layperson responders perform optimal compression rates when using a public access defibrillator with automated real-time feedback during cardiopulmonary resuscitation? 2016 ·IEEE Transactions on Human-Machine Systems ·(unknown), (unknown), Laura Davis, Bruno Delafont, Raymond Bond, (unknown), Anna McLister, (unknown), (unknown), David McEneaney	6
11	Using Machine Learning to Predict if a Profiled Lay Rescuer can Successfully Deliver a Shock using a Public Access Automated External Defibrillator? 2016 ·Computing in cardiology ·Raymond Bond, (unknown), (unknown), Laura Davis, Bruno Delafont, (unknown), Anna McLister, (unknown), (unknown), Dewar Finlay, Daniel Guldenring, James McLaughlin, David McEneaney	1
12	Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis 2015 ·Annals of the American Thoracic Society ·Stephen I. Rennard, Nicholas Locantore, Bruno Delafont, Ruth Tal‐Singer, Edwin K. Silverman, Jørgen Vestbo, Bruce E. Miller, Per Bakke, Bartolomé R. Celli, Peter M.A. Calverley, Harvey O. Coxson, Courtney Crim, Lisa Edwards, David A. Lomas, William MacNee, Emiel F.�M. Wouters, Julie Yates, (unknown), Àlvar Agustí	113
13	An investigation of thrust, depth and the impedance cardiogram as measures of cardiopulmonary resuscitation efficacy in a porcine model of cardiac arrest 2015 ·Resuscitation ·Andrew Howe, (unknown), (unknown), Bruno Delafont, (unknown), (unknown), Eddie Clutton, Jennifer Adgey, David McEneaney	3
14	The correlation between the impedance cardiogram and end-tidal carbon dioxide during cardiopulmonary resuscitation in a porcine model of cardiac arrest 2014 ·Resuscitation ·(unknown), (unknown), (unknown), (unknown), Bruno Delafont, (unknown), Jennifer Adgey	0
15	Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial 2013 ·The Lancet Diabetes & Endocrinology ·Michael Roden, Jianping Weng, (unknown), Bruno Delafont, Gabriel Kim, Hans J. Woerle, Uli C. Broedl	372
16	Prediction of Weight Loss and Regain Following Dietary, Lifestyle, and Pharmacologic Intervention 2012 ·Clinical Pharmacology & Therapeutics ·Antonio Napolitano, Sam R. Miller, Peter R. Murgatroyd, Bruno Delafont, (unknown), Maysoon Elkhawad, Chong Yew Tan, Sam Virtue, Antonio Vidal‐Puig, Derek J. Nunez	11
17	Pragmatic study of orlistat 60 mg on abdominal obesity 2011 ·European Journal of Clinical Nutrition ·E. Louise Thomas, Aidan Makwana, Rexford D. Newbould, (unknown), Giulio Gambarota, Gary Frost, Bruno Delafont, (unknown), Paul M. Matthews, Evan S. Berk, (unknown), Jimmy D. Bell, John D. Beaver	8
18	Determination of COPD characteristics via unsupervised clustering of the ECLIPSE cohort 2011 ·Stephen I. Rennard, Bruno Delafont, Nicholas Locantore, Àlvar Agustí, Peter M.A. Calverley, Edwin K. Silverman, Ruth Tal‐Singer, Jørgen Vestbo	1
19	Distinct Modulatory Effects of Satiety and Sibutramine on Brain Responses to Food Images in Humans: A Double Dissociation across Hypothalamus, Amygdala, and Ventral Striatum 2010 ·Journal of Neuroscience ·Paul C. Fletcher, Antonella Napolitano, (unknown), Sam R. Miller, Bruno Delafont, Victoria C. Cambridge, Sanne de Wit, Pradeep J. Nathan, (unknown), Stephen O’Rahilly, I. Sadaf Farooqi, Edward T. Bullmore	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact